Results 151 to 160 of about 20,263 (262)

Varenicline and Lorcaserin for Smoking Cessation and Weight Gain Prevention: A Randomized Clinical Trial

open access: gold, 2022
Ryan T. Hurt   +6 more
openalex   +1 more source

Which smoking cessation interventions work best? [PDF]

open access: yes, 2011
Nicotine replacement therapy (NRT), bupropion, nortriptyline, clonidine, and varenicline are all effective, although insufficient evidence exists to recommend one intervention over another (SOR: A, systematic reviews).
Flake, Donna   +4 more
core  

Binding Interactions with the Complementary Subunit of Nicotinic Receptors [PDF]

open access: yes, 2013
The agonist-binding site of nicotinic acetylcholine receptors (nAChRs) spans an interface between two subunits of the pentameric receptor. The principal component of this binding site is contributed by an α subunit, and it binds the cationic moiety of ...
Blum, Angela P.   +4 more
core  

Smoking cessation in Asians: focus on varenicline

open access: yesPatient Preference and Adherence, 2015
Dan Xiao,* Shuilian Chu,* Chen Wang Clinical Cessation and Tobacco Medicine Research Centre, China-Japan Friendship Hospital, Beijing, People’s Republic of China *These authors are the co-first authors Abstract: Smoking is a modifiable risk ...
Xiao D, Chu S, Wang C
doaj  

Impact of Continuing Education on Clinicians' Self- Reported Knowledge of Tobacco Dependence and Tobacco Control Interventions [PDF]

open access: yes, 2018
Purpose: To assess a tobacco cessation continuing education (CE) program for Indiana dental and medical providers. Methods: A 26-item immediate post-CE survey and a 19-item 3-month follow-up survey assessed changes in participants’ self-reported ...
Coan, Lorinda, Romito, Laura M.
core  

Effectiveness of varenicline versus nicotine replacement therapy on long-term smoking cessation in primary care: a prospective, cohort study of electronic medical records [PDF]

open access: bronze, 2016
Gemma Taylor   +7 more
openalex   +1 more source

Varenicline for smoking cessation: a narrative review of efficacy, adverse effects, use in at-risk populations, and adherence

open access: yesPatient Preference and Adherence, 2016
Michael V Burke, J Taylor Hays, Jon O Ebbert Mayo Clinic, Rochester, MN, USA Abstract: Treating tobacco dependence is the most effective way to reduce tobacco-related death and disability.
Burke MV, Hays JT, Ebbert JO
doaj  

A case of porphyria cutanea tarda in the setting of hepatitis C infection and tobacco usage [PDF]

open access: yes, 2019
Porphyria cutanea tarda (PCT) is the most common type of porphyria, presenting in middle-aged patients with a photodistributed vesiculobullous eruption, milia, and scars.
Brinster, NK   +4 more
core  

Home - About - Disclaimer - Privacy